2023
DOI: 10.1016/j.chroma.2023.463874
|View full text |Cite
|
Sign up to set email alerts
|

A strategy for assessing peak purity of pharmaceutical peptides in reversed-phase chromatography methods using two-dimensional liquid chromatography coupled to mass spectrometry. Part I: Selection of columns and mobile phases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 18 publications
0
0
0
Order By: Relevance
“…Petersson and co-workers published a series of intriguing papers that investigated 43 RPLC columns to establish a column characterization database to help identify backup columns for existing methods and highlight complementary stationary-phase combinations with significant selectivity differences for method development [30,31]. The same group then described strategies for assessing the peak purity of therapeutic peptides, where they focused on the selection of columns and mobile phases [32]. After their developed protocol for column characterization, they established a column characterization database.…”
Section: Reversed-phase Liquid Chromatography (Rplc)mentioning
confidence: 99%
“…Petersson and co-workers published a series of intriguing papers that investigated 43 RPLC columns to establish a column characterization database to help identify backup columns for existing methods and highlight complementary stationary-phase combinations with significant selectivity differences for method development [30,31]. The same group then described strategies for assessing the peak purity of therapeutic peptides, where they focused on the selection of columns and mobile phases [32]. After their developed protocol for column characterization, they established a column characterization database.…”
Section: Reversed-phase Liquid Chromatography (Rplc)mentioning
confidence: 99%
“…Figure 9 in Part I of this study[15] and Fig.6in this paper show results from the application of the method development workflow in two additional laboratories.Figure 9 in Part I shows chromatograms obtained from a peak purity analysis of a method developed for the peptide [L-Ser5]-GLP2 (1-15) in Laboratory C. In order to evaluate the suggested strategy a sample of [L-Ser5]-GLP2 (1-15) was spiked with 12% of a racemisation product [D-Ser5]-GLP-2(1-15) which coelutes in the method for which peak purity should be assessed. Subsequently retention data from three different gradient slopes were used to…”
mentioning
confidence: 94%